1. Integrated Diabetes Care: How Can We Make the Best Use of New Technology?

3. Program Overview

4. Why Insulin Is Needed in Patients With T2DM

5. Evidence for the Benefits of Early Tight Glycemic Control: UKPDS

6. Clinical Inertia

7. Clinical Inertia With Insulin Therapy

8. Adherence/Persistence With Insulin Therapy

9. Clinical Inertia: PCPs

10. Concerns About Hypoglycemia

11. Oral Agents That Reduce the Risk for Hypoglycemia: DPP-4i and SGLT2i

12. Novel Basal Insulins: Degludec

13. Novel Basal Insulins: Gla-300

14. Gla-300: Less Weight Gain Than With First-Generation Glargine (Gla-100)

15. Novel Insulins in Clinical Practice

16. Insulin Therapy: The Role of Technology

17. Glucose Monitoring

18. Glucose Monitoring (cont)

19. Titrating Insulin

20. Titrating Insulin (cont)

21. Insulin Delivery

22. Insulin Delivery (cont)

23. Technology for Patient Support and Education

24. Technology for Reducing the Risk for Hypoglycemia

25. Technology for More Effective Patient Care and Management

26. Summary

27. Abbreviations

28. Abbreviations (cont)